{
    "N/R/U": null,
    "Applicant": "Bristol-Myers Squibb Company",
    "BLA Number": "125554",
    "Proprietary Name": "Opdivo",
    "Proper Name": "nivolumab",
    "BLA Type": "351(a)",
    "Strength": "120MG/12ML (10MG/ML)",
    "Dosage Form": "Injection ",
    "Route of Administration": "Intravenous",
    "Product Presentation": "Single-Dose Vial",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "August 27, 2021",
    "Ref. Product Proper Name": null,
    "Ref. Product Proprietary Name": null,
    "Supplement Number": "103",
    "Submission Type": "Supplement",
    "License Number": "1713",
    "Product Number": "004",
    "Center": "CDER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": "October 13, 2030",
    "drug": [
        {
            "name": "nivolumab",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_231614"
        }
    ]
}